Back
Fate Therapeutics 10K Form
Sell
27
FATE
Fate Therapeutics
Last Price:
5.28
Seasonality Move:
6.08%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-08 | 10Q | FATE/Fate Therapeutics Quarterly |
2023-08-08 | 10Q | FATE/Fate Therapeutics Quarterly |
2023-05-03 | 10Q | FATE/Fate Therapeutics Quarterly |
2022-11-03 | 10Q | FATE/Fate Therapeutics Quarterly |
2022-08-03 | 10Q | FATE/Fate Therapeutics Quarterly |
2022-05-04 | 10Q | FATE/Fate Therapeutics Quarterly |
Receive FATE News And Ratings
See the #1 stock for the next 7 days that we like better than FATE
FATE Financial Statistics
Sales & Book Value
Annual Sales: | $63.53M |
---|---|
Cash Flow: | $-36.82M |
Price / Cash Flow: | 0 |
Annual Sales: | $3.74 |
Price / Book: | 1.42 |
Profitability
EPS (TTM): | -1.64000 |
---|---|
Net Income (TTM): | $-160.93M |
Gross Margin: | $0 |
Return on Equity: | -37.07% |
Return on Assets: | -27.09% |
Fate Therapeutics Earnings Forecast
Key Fate Therapeutics Financial Ratios
- The Gross Profit Margin over the past 4 years for FATE is 0.00%.
- The Selling, General & Administrative Expenses for FATE have been equal to 128.20% of Gross Profit Margin.
- The Research & Development expenses have been 271.66% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of FATE is -253.30% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 5 years.
Fate Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | FATE |
CUSIP: | 31189P |
Website: | fatetherapeutics.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 8.48 |
Quick Ratio: | 8.11 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
FATE Technical Analysis vs Fundamental Analysis
Sell
27
Fate Therapeutics (FATE)
is a Sell
Is Fate Therapeutics a Buy or a Sell?
-
Fate Therapeutics stock is rated a Sell
The current Fate Therapeutics [FATE] share price is $5.27. The Score for FATE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.